Prescribing indications based on successful clinical trials in sepsis: A difficult exercise

被引：27
作者：
Carlet, J [1 ]
机构：
[1] Fdn Hop St Joseph, Intens Care Unit, Paris, France
[2] Fdn Hop St Joseph, Dept Infect Dis, Paris, France
来源：
CRITICAL CARE MEDICINE | 2006年 / 34卷 / 02期
关键词：
D O I：
10.1097/01.CCM.0000198329.85851.8E
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
[No abstract available]
引用
收藏
页码：525 / 529
页数：5
相关论文
共 28 条
[1]   Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death [J].
Abraham, E ;
Laterre, P ;
Garg, R ;
Levy, H ;
Talwar, D ;
Trzaskoma, BL ;
Francois, B ;
Guy, JS ;
Bruckmann, M ;
Rea-Neto, A ;
Rossaint, R ;
Perrotin, D ;
Sablotzki, A ;
Arkins, N ;
Utterback, BG ;
Macias, WL .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) :1332-1341
[2]   The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis [J].
Angus, DC ;
Laterre, PF ;
Helterbrand, J ;
Ely, EW ;
Ball, DE ;
Garg, R ;
Weissfeld, LA ;
Bernard, GR .
CRITICAL CARE MEDICINE, 2004, 32 (11) :2199-2206
[3]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[4]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[5]   EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units [J].
Brun-Buisson, C ;
Meshaka, P ;
Pinton, P ;
Vallet, B ;
Rodie-Talbere, P ;
Zahar, JR .
INTENSIVE CARE MEDICINE, 2004, 30 (04) :580-588
[6]   INCIDENCE, RISK-FACTORS, AND OUTCOME OF SEVERE SEPSIS AND SEPTIC SHOCK IN ADULTS - A MULTICENTER PROSPECTIVE-STUDY IN INTENSIVE-CARE UNITS [J].
BRUNBUISSON, C ;
DOYON, F ;
CARLET, J ;
DELLAMONICA, P ;
GOUIN, F ;
LEPOUTRE, A ;
MERCIER, JC ;
OFFENSTADT, G ;
REGNIER, B .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (12) :968-974
[7]   Looking at subgroups in an inhomogeneous population does not make these subgroups more homogeneous [J].
Carlet, J .
INTENSIVE CARE MEDICINE, 2004, 30 (07) :1497-1497
[8]  
Carlet J, 2003, CRIT CARE MED, V31, P2564, DOI 10.1097/01.CCM.0000089929.73924.4C
[9]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[10]  
Cohen J, 2004, CRIT CARE MED, V32, P1510, DOI [10.1097/01.CCM.0000129973.13104.2D, 10.1097/01.CCM.0000145917.89975.F5]
123